Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-08-21
1996-12-10
McKane, Joseph
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514256, 514269, 514415, 544242, 544298, 544319, 544330, 544333, 546273, 5462774, 548469, 548509, 548510, 548511, A61K 3144, C07D40110
Patent
active
055831494
ABSTRACT:
A series of novel serotonergic indolyl derivatives of cycloalkanyl- and cycloalkenyl-amines of Formula I are intended for use in the alleviation of vascular headaches. ##STR1##
REFERENCES:
patent: 3238215 (1966-03-01), Zenitz
patent: 4252803 (1981-02-01), Webb
patent: 4954502 (1990-09-01), Smith et al.
patent: 5124332 (1992-06-01), Wise et al.
Chemical Abstracts, vol. 65, No. 5, Aug. 29, 1966.
Glennon et al, "5-HT1D Serotonin Receptors: Results of a Structure-Affinity Investigation," Drug Development Research, vol. 22, 1991, pp. 25-36.
Cipollina Joseph A.
Gylys Jonas A.
Mattson Ronald J.
Sloan Charles P.
Bristol--Myers Squibb Company
McKane Joseph
Ryan Richard P.
LandOfFree
Antimigraine derivatives of indolylcycloalkanylamines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antimigraine derivatives of indolylcycloalkanylamines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antimigraine derivatives of indolylcycloalkanylamines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-424508